this PDF file - Pakistan Heart Journal
... usually arise from occlusion of the right coronary artery and occasionally from occlusion of a posterior descending branch arising from the circumflex artery in a left dominant system. These wall motion abnormalities are well seen in the short axis but even better by using the apical two chamber vie ...
... usually arise from occlusion of the right coronary artery and occasionally from occlusion of a posterior descending branch arising from the circumflex artery in a left dominant system. These wall motion abnormalities are well seen in the short axis but even better by using the apical two chamber vie ...
Sep Summary
... The last decade witnessed a big advance in the use of mechanical circulatory support devices. Two Heart Mate II trials have shown a significant survival benefit with continuous flow (CF) left ventricular assist devices (LVADs) over pulsatile devices in patients with advanced heart failure (HF). In a ...
... The last decade witnessed a big advance in the use of mechanical circulatory support devices. Two Heart Mate II trials have shown a significant survival benefit with continuous flow (CF) left ventricular assist devices (LVADs) over pulsatile devices in patients with advanced heart failure (HF). In a ...
Nonsustained ventricular tachycardia
... NSVT as an important prognostic determinant for arrhythmic death, even independent of left ventricular ejection fraction (LVEF).36;37 It now appears that in the patient with ischaemic heart disease, NSVT no longer appears to be an independent predictor of death if other factors such as the ejection ...
... NSVT as an important prognostic determinant for arrhythmic death, even independent of left ventricular ejection fraction (LVEF).36;37 It now appears that in the patient with ischaemic heart disease, NSVT no longer appears to be an independent predictor of death if other factors such as the ejection ...
Aorto-cavitary fistulous tract formation in infective endocarditis
... on mortality. All factors with a simple P-value ,0.15 were added stepwise to a multiple model. All P-values were based on two-sided testing with a 95% confidence interval (CI). The logistic regression model was calculated with Stata statistical software (Release 7.0. College Station, Stata Corporatio ...
... on mortality. All factors with a simple P-value ,0.15 were added stepwise to a multiple model. All P-values were based on two-sided testing with a 95% confidence interval (CI). The logistic regression model was calculated with Stata statistical software (Release 7.0. College Station, Stata Corporatio ...
Use of beta-blockers in outpatients with stable CAD
... heart failure and post-MI (10-12,21), these agents have been used to prevent MI or death, and their cardioprotective effects have been broadly extrapolated to all patients with stable CAD, including those without MI. It is not known, however, if these extrapolations are justified. Moreover, the long ...
... heart failure and post-MI (10-12,21), these agents have been used to prevent MI or death, and their cardioprotective effects have been broadly extrapolated to all patients with stable CAD, including those without MI. It is not known, however, if these extrapolations are justified. Moreover, the long ...
External compression of superior vena cava after the replacement of
... Right ventricle appeared mildly hypokinetic. Moderate eccentric MR and moderate central tricuspid regurgitation (TR) were also identified. The patient was taken back to the operating room for chest exploration. Surgical exposure uncovered an intrapericardial thrombus around the aortic graft compressi ...
... Right ventricle appeared mildly hypokinetic. Moderate eccentric MR and moderate central tricuspid regurgitation (TR) were also identified. The patient was taken back to the operating room for chest exploration. Surgical exposure uncovered an intrapericardial thrombus around the aortic graft compressi ...
Thread-like strand from right atrium into right ventricle - Heart
... long strand seen in this patient with its tent-like attachment could also be a remnant of the phase of development when the interatrial and atrioventricular walls are formed. It is impossible to say whether it has anything to do with the short fibrous bands Necropsy The heart weighed 690 g; both ven ...
... long strand seen in this patient with its tent-like attachment could also be a remnant of the phase of development when the interatrial and atrioventricular walls are formed. It is impossible to say whether it has anything to do with the short fibrous bands Necropsy The heart weighed 690 g; both ven ...
2012-gemc-res-sagalyn-basic_arrythmias-edited
... A new LBBB + symptoms of ischemic heart disease = Acute MI until proven otherwise ...
... A new LBBB + symptoms of ischemic heart disease = Acute MI until proven otherwise ...
Effect of Abana on ventricular function in ischaemic heart disease
... 0.30 to 3.06 ± 0.19 mm. Twenty-two patients were able to complete stage 3 in TM exercise at the end of the treatment period as compared to 17 patients at the beginning7. In the other study of Abana in unstable angina, Satyamurthy et al. observed definite improvement in the anginal status with Abana ...
... 0.30 to 3.06 ± 0.19 mm. Twenty-two patients were able to complete stage 3 in TM exercise at the end of the treatment period as compared to 17 patients at the beginning7. In the other study of Abana in unstable angina, Satyamurthy et al. observed definite improvement in the anginal status with Abana ...
Reducing Heart Failure Readmissions: Case Studies Utilizing
... Arranging for follow-up visits before discharge Having a process in place to send discharge or electronic summaries directly to the patient’s primary care physician 6. Assigning staff to follow up on test results after the patient is discharged The more strategies are used by a single institution, t ...
... Arranging for follow-up visits before discharge Having a process in place to send discharge or electronic summaries directly to the patient’s primary care physician 6. Assigning staff to follow up on test results after the patient is discharged The more strategies are used by a single institution, t ...
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure
... budget that year.1 In the United States, approximately $500 million annually is spent on drugs for the treatment of HF. The American College of Cardiology (ACC) and the American Heart Association (AHA) first published guidelines for the evaluation and management of HF in 1995.6 Since that time, a gr ...
... budget that year.1 In the United States, approximately $500 million annually is spent on drugs for the treatment of HF. The American College of Cardiology (ACC) and the American Heart Association (AHA) first published guidelines for the evaluation and management of HF in 1995.6 Since that time, a gr ...
قصور القلب - تدبير ومعالجة
... HFrEF. Hormonal therapies other than to correct deficiencies are not recommended for patients with current or prior symptoms of HFrEF. Drugs known to adversely affect the clinical status of patients with current or prior symptoms of HFrEF are potentially harmful and should be avoided or withdrawn wh ...
... HFrEF. Hormonal therapies other than to correct deficiencies are not recommended for patients with current or prior symptoms of HFrEF. Drugs known to adversely affect the clinical status of patients with current or prior symptoms of HFrEF are potentially harmful and should be avoided or withdrawn wh ...
Holter Monitoring (Ambulatory Electrocardiography) Defined
... Abstract: Palpitation is non-specific and represents one of the most common symptoms in general medical settings. Discerning cardiac from noncardiac causes is important. A 24-hour ambulatory electrocardiography (Holter) monitor is usually used. This is a retrospective cross-sectional review includin ...
... Abstract: Palpitation is non-specific and represents one of the most common symptoms in general medical settings. Discerning cardiac from noncardiac causes is important. A 24-hour ambulatory electrocardiography (Holter) monitor is usually used. This is a retrospective cross-sectional review includin ...
Relationship between urolithiasis and diastolic functions of the heart
... that reduction in functional capacity is similar in patients with diastolic dysfunction and systolic dysfunction (8), * Correspondence: [email protected] ...
... that reduction in functional capacity is similar in patients with diastolic dysfunction and systolic dysfunction (8), * Correspondence: [email protected] ...
Acute Treatment of ST-Segment-Elevation Myocardial
... presence of a left main stem stenosis the optimal treatment? In the acute treatment of STEMI, PTCA is concentrated on the one target vessel responsible for the ischemia or infarction. This can leave a significant number of patients with an incomplete revascularization and the necessity for further i ...
... presence of a left main stem stenosis the optimal treatment? In the acute treatment of STEMI, PTCA is concentrated on the one target vessel responsible for the ischemia or infarction. This can leave a significant number of patients with an incomplete revascularization and the necessity for further i ...
EKG Final Exam TEST A - 50 questions
... B. NSR @ 81, Right axis, LBBB, 1st degree AV block C. NSR @81, Left axis, LBBB, 1st degree AV block D. NSR @81, Right axis, RBBB, 1st degree AV block 45 Which of the following clinical scenarios could explain this EKG? A. Left ventricular hypertrophy B. Pulmonary embolism C. Hyperkalemia D. Hypother ...
... B. NSR @ 81, Right axis, LBBB, 1st degree AV block C. NSR @81, Left axis, LBBB, 1st degree AV block D. NSR @81, Right axis, RBBB, 1st degree AV block 45 Which of the following clinical scenarios could explain this EKG? A. Left ventricular hypertrophy B. Pulmonary embolism C. Hyperkalemia D. Hypother ...
Objectives ACLS Medications
... Epinephrine Alpha-adrenergic effects • Vasoconstrictor • cerebral and coronary blood flow • Mean Arterial Pressure • aortic diastolic pressure • ACLS dose: 1 mg ...
... Epinephrine Alpha-adrenergic effects • Vasoconstrictor • cerebral and coronary blood flow • Mean Arterial Pressure • aortic diastolic pressure • ACLS dose: 1 mg ...
The Electrocardiogram (ECG)
... powerful diagnostic tool by Cardiologists (medical doctors specializing in the human heart). • It identifies a time sequence of the contractions of the left and right chambers of the heart – the mechanisms by which blood is circulated through the body. ...
... powerful diagnostic tool by Cardiologists (medical doctors specializing in the human heart). • It identifies a time sequence of the contractions of the left and right chambers of the heart – the mechanisms by which blood is circulated through the body. ...
Relation of systemic and local muscle exercise capacity to
... Objectives. The present study was undertaken to further characterize changes in skeletal muscle morphology and histochemistry in congestive heart failure and to determine the relation of these changes to abnormalities of systemic and local muscle exercise capacity. Background. Abnormalities of skele ...
... Objectives. The present study was undertaken to further characterize changes in skeletal muscle morphology and histochemistry in congestive heart failure and to determine the relation of these changes to abnormalities of systemic and local muscle exercise capacity. Background. Abnormalities of skele ...
Atrial Septal Defect
... option available to some patients. The procedure involves making a small incision, typically in the groin, and inserting a small tube, called a catheter or sheath, to navigate through the blood vessels to the procedure site within the heart (Figure 4). In patients with an ASD, the doctor guides the ...
... option available to some patients. The procedure involves making a small incision, typically in the groin, and inserting a small tube, called a catheter or sheath, to navigate through the blood vessels to the procedure site within the heart (Figure 4). In patients with an ASD, the doctor guides the ...
Cardiogenic Shock Complicating Acute Myocardial
... high. Renal failure, late onset of shock, hyperglycemia and the anterior territory of MI were the major predictive of hospital mortality. A multidisciplinary approach including medical actors and pre-hospital centers specialized in the treatment of this condition is actually necessary. ...
... high. Renal failure, late onset of shock, hyperglycemia and the anterior territory of MI were the major predictive of hospital mortality. A multidisciplinary approach including medical actors and pre-hospital centers specialized in the treatment of this condition is actually necessary. ...
Amiodarone - Health Sciences North
... blocks sodium channels at rapid pacing frequencies, and like Class II drugs, it exerts antisympathetic activity. One of its main effects, with prolonged administration, is to lengthen the cardiac action potential, a Class III effect. The negative chronotropic effect of Amiodarone in nodal tissues is ...
... blocks sodium channels at rapid pacing frequencies, and like Class II drugs, it exerts antisympathetic activity. One of its main effects, with prolonged administration, is to lengthen the cardiac action potential, a Class III effect. The negative chronotropic effect of Amiodarone in nodal tissues is ...
Cardiac Memory and Review
... apicobasal changes in repolarization occur with longterm CM has not yet been investigated. CM also has been described in canine atrium, via calculation of an atrial gradient from X, Y, and Z loops of PTa waves.7 Pacing from sites that alter atrial activation (e.g., left atrial appendage) induces an ...
... apicobasal changes in repolarization occur with longterm CM has not yet been investigated. CM also has been described in canine atrium, via calculation of an atrial gradient from X, Y, and Z loops of PTa waves.7 Pacing from sites that alter atrial activation (e.g., left atrial appendage) induces an ...
The Atrial Fibrillation And Stroke Thromboprophylaxis in hEart
... I would like to express my thanks to my supervisors Dr. Sally Inglis & Dr. Phil Newton, and Professor Peter Macdonald for the practical supervision during my candidacy. I am forever indebted. To my peers and colleagues in the Centre and the Faculty I thank for your support. There are far too many to ...
... I would like to express my thanks to my supervisors Dr. Sally Inglis & Dr. Phil Newton, and Professor Peter Macdonald for the practical supervision during my candidacy. I am forever indebted. To my peers and colleagues in the Centre and the Faculty I thank for your support. There are far too many to ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.